- Home
- ZLAB vs LMAT Comparison
ZLAB vs LMAT Comparison
Compare ZLAB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- LMAT
- Stock Information
- Founded
- ZLAB 2013
- LMAT 1983
- Country
- ZLAB China
- LMAT United States
- Employees
- ZLAB N/A
- LMAT N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- LMAT Medical/Dental Instruments
- Sector
- ZLAB Health Care
- LMAT Health Care
- Exchange
- ZLAB Nasdaq
- LMAT Nasdaq
- Market Cap
- ZLAB 3.6B
- LMAT 1.9B
- IPO Year
- ZLAB 2017
- LMAT 2006
- Fundamental
- Price
- ZLAB $35.33
- LMAT $84.45
- Analyst Decision
- ZLAB Buy
- LMAT Buy
- Analyst Count
- ZLAB 5
- LMAT 6
- Target Price
- ZLAB $54.28
- LMAT $100.80
- AVG Volume (30 Days)
- ZLAB 839.0K
- LMAT 151.4K
- Earning Date
- ZLAB 08-05-2025
- LMAT 07-31-2025
- Dividend Yield
- ZLAB N/A
- LMAT 0.95%
- EPS Growth
- ZLAB N/A
- LMAT 30.45
- EPS
- ZLAB N/A
- LMAT 1.97
- Revenue
- ZLAB $418,326,000.00
- LMAT $226,256,000.00
- Revenue This Year
- ZLAB $44.07
- LMAT $13.88
- Revenue Next Year
- ZLAB $49.13
- LMAT $8.81
- P/E Ratio
- ZLAB N/A
- LMAT $42.77
- Revenue Growth
- ZLAB 43.72
- LMAT 13.19
- 52 Week Low
- ZLAB $16.01
- LMAT $71.42
- 52 Week High
- ZLAB $44.34
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- ZLAB 47.54
- LMAT 55.03
- Support Level
- ZLAB $34.79
- LMAT $82.76
- Resistance Level
- ZLAB $36.97
- LMAT $84.72
- Average True Range (ATR)
- ZLAB 1.19
- LMAT 1.96
- MACD
- ZLAB -0.44
- LMAT 0.18
- Stochastic Oscillator
- ZLAB 15.85
- LMAT 82.43
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.